Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

Noam Barda, Noa Dagan, Yatir Ben‐Shlomo, +9

New England Journal of Medicine

Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge

Ronen Arbel, Yael Wolff Sagy, Moshe Hoshen, +13

New England Journal of Medicine

Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals

Talia Kustin, Noam Harel, Uriah Finkel, +26

Nature Medicine

Vaccine SeraImmunologyBroad-spectrum VaccinesCovid-19Sars-cov-2 Variants +16

Real-world effectiveness of a single dose of mpox vaccine in males

Yael Wolff Sagy, Roy Zucker, Ariel Hammerman, +14

Nature Medicine

VaccinationAllergyReal-world EffectivenessSingle DosePrecision Vaccinology +5

Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study

Ronen Arbel, Alon Peretz, Ruslan Sergienko, +7

The Lancet Infectious Diseases

VaccinationVaccine SafetyRetrospective Cohort StudyPreventive MedicineImmunology +7

Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years

Ronen Arbel, Ruslan Sergienko, Michael Friger, +5

Nature Medicine

VaccinationVaccine SafetyVaccinologyPreventive MedicineVaccine Development +5

Developing a COVID-19 mortality risk prediction model when individual-level data are not available

Noam Barda, Dan Riesel, Amichay Akriv, +12

Nature Communications

Evaluating the impact of an evidence‐based medicine educational intervention on primary care doctors’ attitudes, knowledge and clinical behaviour: a controlled trial and before and after study

Kerem Shuval, Eldar Berkovits, Doron Netzer, +4

Journal of Evaluation in Clinical Practice

BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age

Chandra J. Cohen-Stavi, Ori Magen, Noam Barda, +11

New England Journal of Medicine

Safety of monovalent and bivalent BNT162b2 mRNA COVID-19 vaccine boosters in at-risk populations in Israel: a large-scale, retrospective, self-controlled case series study

Dan Yamin, Matan Yechezkel, Ronen Arbel, +7

The Lancet Infectious Diseases

VaccinationVaccine SafetyCovid-19 Vaccine BoostersAt-risk PopulationsVaccine Development +9